Delivery Order SPE2DR25D7066-SPE2DR26F7ZFC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count packages) valued at $1,383.72 with a completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $3,900.48 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). The contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.58 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Promethegan 12.5 mg suppositories (quantity: 12 units) with a ceiling value of $1,950.24. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation and was competitively awarded. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,446.72 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,335.72 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 units) on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as a child...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promethegan 25 mg suppositories (12-count units) with a ceiling value of $14,649.54. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive award issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,875.57 to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12 count), with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZFCDelivery Order
The Defense Logistics Agency awarded a $2,068.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12 count) on November 18, 2025, with an ultimate completion date of November 19, 2025. The award was made without a set-aside designation through competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value transaction within the company's broader pharmaceutical supply relationship with the federal government. This award operates as a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen has demonstrated capability to fulfill diverse federal medical procurement requirements through its extensive portfolio of competitively awarded contracts spanning multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/18/25 |